Viabahn Stent Graft and VBX Endoprosthesis: Scoping Review with ☸️SAIMSARA.

Name: SAIMSARA Evidence Object vascular::VIABAHN_STENT_SS
Creator: SAIMSARA
License: https://saimsara.com/license/

SAIMSARA

doi:10.62487/saimsarae1c09738

SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Viabahn Stent Graft and VBX Endoprosthesis: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

Chat with this issue

DOI: 10.62487/saimsarae1c09738

Editorial note

• Last update: 2026-05-29 22:56:49

What is this paper about

Viabahn is not one device story but a whole vascular strategy: emergency bleeding control, femoropopliteal reconstruction, dialysis-access salvage, aneurysm exclusion, and complex aortic bridging all appear in the evidence map. The full review separates where Viabahn and VBX look durable from where patency depends heavily on anatomy, sizing, runoff, mobility zones, and antiplatelet planning.

Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.

Abstract: To map and synthesize original studies addressing the use, outcomes, complications, predictors of patency, and emerging procedural applications of Viabahn stent grafts and Viabahn VBX endoprostheses across vascular territories. The review uses 144 references and builds its evidence map from 313 original studies with 12701 total participants/sample observations (topic-deduplicated ΣN). The mapped evidence indicates that Viabahn and Viabahn VBX devices function as versatile covered conduits with consistently high immediate technical success, but durability is strongly shaped by indication, anatomy, sizing, and adjunctive therapy rather than by the device itself. Recurrent signals across femoropopliteal, dialysis access, and aneurysm applications suggest that primary patency varies widely while secondary patency often remains favorable, as illustrated by 36-month primary patency of 40.6% alongside secondary patency of 96.9% in very long femoropopliteal lesions. Comparative data also highlight modifiable factors, including a reduction in 12-month restenosis from 27.3% to 8.2% with adjunctive cilostazol, and configuration-dependent dialysis access outcomes. These findings support a role for Viabahn as an anatomy- and indication-specific strategy embedded within structured surveillance and antiplatelet planning. Future randomized comparative trials with harmonized patency endpoints across defined vascular beds are needed to clarify where Viabahn offers durable advantage over alternative covered, drug-eluting, or surgical options.

Keywords: Viabahn stent graft; Endovascular treatment; Arterial injury; Pseudoaneurysm; Femoropopliteal disease; Stent patency; Hemodialysis access; Visceral artery injury; Carotid blowout syndrome; Stent thrombosis

Review Stats

Final search date and database lock: 2026-05-20 21:56:28 CEST
Plan: Pro (expanded craft tokens; source: Semantic Scholar)
Source: Semantic Scholar
Total Abstracts/Papers: 256342
Downloaded Abstracts/Papers: 1000
Included original and non-original Abstracts/Papers (all): 340
Included original Abstracts/Papers (Vote counting by direction of effect): 313
Reference Index (links used in paper): 144
Total participants/sample observations (topic deduplicated ΣN): 12701

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (144)

[1] Viabahn stent graft for arterial injury management: safety, technical success, and long-term outcome — https://doi.org/10.1186/s42155-024-00435-9
[2] Ruptured Infected Pseudoaneurysms of Bilateral Carotid Artery Treated with Viabahn Stent Graft: A Case Report — https://doi.org/10.22575/interventionalradiology.2024-0034
[3] Limb salvage using Viabahn stent grafts for femoral and popliteal artery disruptions following bilateral type III open femur fractures from crush injury — https://doi.org/10.1016/j.jvscit.2025.102024
[4] Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study — https://doi.org/10.5551/jat.63874
[5] Clinical Outcomes and Risk Factors for Viabahn Stent Graft Occlusion in the Treatment of Visceral Arterial Injuries in Cancer Patients — https://doi.org/10.22575/interventionalradiology.2023-0040
[6] Post neck radiation cancer carotid pseudoaneurysm blowouts with Viabahn stent placement. — https://doi.org/10.1016/j.avsg.2024.08.015
[7] Endovascular treatment with Viabahn stent-grafts for arterial injury and bleeding at the visceral arteries: initial and midterm results — https://doi.org/10.1007/s11604-021-01192-8
[8] Emergency endovascular treatment using a Viabahn stent graft for upper and lower extremity arterial bleeding: a retrospective study — https://doi.org/10.1186/s42155-021-00273-z

Unlock the full paper to view the complete Reference Index.